117 related articles for article (PubMed ID: 38145897)
1. Modulation of immunosuppressive effect of rapamycin via microfluidic encapsulation within PEG-PLGA nanoparticles.
Wu W; Liu R; Guo J; Hu Z; An C; Zhang Y; Liu T; Cen L; Pan Y
J Biomater Appl; 2024 Feb; 38(7):821-833. PubMed ID: 38145897
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic nanoprecipitation of PEGylated PLGA nanoparticles with rapamycin and performance evaluation.
Guo J; Dai W; Wu W; Zhuang S; Zhang H; Cen L
J Biomater Sci Polym Ed; 2024 Jun; 35(8):1197-1213. PubMed ID: 38421916
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic preparation of PLGA microspheres as cell carriers with sustainable Rapa release.
Zhu C; Yang H; Shen L; Zheng Z; Zhao S; Li Q; Yu F; Cen L
J Biomater Sci Polym Ed; 2019; 30(9):737-755. PubMed ID: 30935290
[TBL] [Abstract][Full Text] [Related]
4. The Use of an Efficient Microfluidic Mixing System for Generating Stabilized Polymeric Nanoparticles for Controlled Drug Release.
Morikawa Y; Tagami T; Hoshikawa A; Ozeki T
Biol Pharm Bull; 2018; 41(6):899-907. PubMed ID: 29863078
[TBL] [Abstract][Full Text] [Related]
5. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
6. Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology.
Mares AG; Pacassoni G; Marti JS; Pujals S; Albertazzi L
PLoS One; 2021; 16(6):e0251821. PubMed ID: 34143792
[TBL] [Abstract][Full Text] [Related]
7. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications.
Zhang K; Tang X; Zhang J; Lu W; Lin X; Zhang Y; Tian B; Yang H; He H
J Control Release; 2014 Jun; 183():77-86. PubMed ID: 24675377
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic Manufacturing of Multitargeted PLGA/PEG Nanoparticles for Delivery of Taxane Chemotherapeutics.
Martins C; Sarmento B
Methods Mol Biol; 2020; 2059():213-224. PubMed ID: 31435924
[TBL] [Abstract][Full Text] [Related]
10. Co-encapsulation of magnetic Fe
Liang C; Li N; Cai Z; Liang R; Zheng X; Deng L; Feng L; Guo R; Wei B
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4211-4221. PubMed ID: 31713444
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immunosuppressive effects of 3,5-bis[4(diethoxymethyl)benzylidene]-1-methyl-piperidin-4-one, an α, β-unsaturated carbonyl-based compound as PLGA-
Arshad L; Jantan I; Bukhari SNA
Drug Des Devel Ther; 2019; 13():1421-1436. PubMed ID: 31118577
[No Abstract] [Full Text] [Related]
12. Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells.
Faramarzi L; Dadashpour M; Sadeghzadeh H; Mahdavi M; Zarghami N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):737-746. PubMed ID: 30892093
[TBL] [Abstract][Full Text] [Related]
13. Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo.
Shi P; Aluri S; Lin YA; Shah M; Edman M; Dhandhukia J; Cui H; MacKay JA
J Control Release; 2013 Nov; 171(3):330-8. PubMed ID: 23714121
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic-assisted synthesis of multifunctional iodinated contrast agent polymeric nanoplatforms.
Chiesa E; Greco A; Dorati R; Conti B; Bruni G; Lamprou D; Genta I
Int J Pharm; 2021 Apr; 599():120447. PubMed ID: 33676989
[TBL] [Abstract][Full Text] [Related]
15. Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform.
Bao Y; Maeki M; Ishida A; Tani H; Tokeshi M
PLoS One; 2022; 17(8):e0271050. PubMed ID: 35925917
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of three-arm block copolymer poly(lactic-
Zhu X; Liu C; Duan J; Liang X; Li X; Sun H; Kong D; Yang J
Int J Nanomedicine; 2016; 11():6065-6077. PubMed ID: 27895480
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight PEG-PLGA polymers provide a superior matrix for conjugated polymer nanoparticles in terms of physicochemical properties, biocompatibility and optical/photoacoustic performance.
Abelha TF; Neumann PR; Holthof J; Dreiss CA; Alexander C; Green M; Dailey LA
J Mater Chem B; 2019 Sep; 7(33):5115-5124. PubMed ID: 31363720
[TBL] [Abstract][Full Text] [Related]
18. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
[TBL] [Abstract][Full Text] [Related]
19. Influence of Albumin in the Microfluidic Synthesis of PEG-PLGA Nanoparticles.
Poller B; Painter GF; Walker GF
Pharm Nanotechnol; 2019; 7(6):460-468. PubMed ID: 31657694
[TBL] [Abstract][Full Text] [Related]
20. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
